Lixte Biotechnology Holdings, Inc.

NASDAQ:LIXT

Biotechnology

Healthcare
$7.21 +6.61%

+$0.46 today

Market cap
$89.11M
Beta
1.05
P/E (TTM)
-11.1
EPS (TTM)
-$0.67
52W Low $0.68High $7.78

Volume 0.61M

Average 0.12M

Balance Sheet

Inspect the capital base behind the business.

Assets

$12.73M

FY 2025 · Annual

+1011.6% YoY

Liabilities

$1.77M

FY 2025 · Annual

+456.8% YoY

Equity

$10.96M

FY 2025 · Annual

+1225.1% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents4.82M5.35M4.2M1.04M5.11M
Short-term Investments00000
Net Receivables00000
Inventory00000
Other Current Assets150.24K00(106.55K)0
Total Current Assets5.09M5.56M4.31M1.04M5.18M
Property, Plant & Equipment (Net)00007.56M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets000106.55K0
Total Non-current Assets000106.55K7.56M
Total Assets5.09M5.56M4.31M1.15M12.73M
Account Payables193.47K183.75K120.51K83.21K436.48M
Short-term Debt000069.07K
Tax Payables00000
Deferred Revenue0165.02K157.1K235.08K232.14K
Other Current Liabilities76.96K000(436.05M)
Total Current Liabilities302.93K395.76K313.86K318.28K1.33M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities(0)000438.96K
Total Non-current Liabilities(0)000438.96K
Total Liabilities302.93K395.76K313.86K318.28K1.77M
Common Stock1.37K166225225879
Retained Earnings(37.08M)(43.39M)(48.48M)(52.07M)(58.08M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00001.3M
Total Equity4.79M5.17M3.99M827.22K10.96M
Total Debt0000664.49K
Net Debt(4.82M)(5.35M)(4.2M)(1.04M)(4.44M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$3.3M
Other Current$157.1K
Total Current Assets$3.4M
PP&E (Net)$850.1K
Other Non-current$6.6M
Total Non-current Assets$7.5M
Total Assets$10.9M

Analysis

Selected assets total $10.9M for Latest. The largest visible component is Other Non-current at $6.6M, about 60.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
3Initial statement of beneficial ownershipJul 2, 2026
4Statement of changes in beneficial ownershipJul 2, 2026
4Statement of changes in beneficial ownershipJul 2, 2026
4Statement of changes in beneficial ownershipJul 2, 2026
4Statement of changes in beneficial ownershipJul 2, 2026

How much cash does LIXT have?

Lixte Biotechnology Holdings, Inc. (LIXT) reported $5.11M in cash and equivalents in fiscal 2025.

How much debt does LIXT carry?

Lixte Biotechnology Holdings, Inc. (LIXT) reported $664,491.00 of total debt, with net debt of -$4.44M.